World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Neuroscience
Australia
2026

D-Index & Metrics

Best Scientists

D-Index
175
Citations
129343
World Ranking
713
National Ranking
17

Neuroscience

D-Index
177
Citations
135818
World Ranking
60
National Ranking
2

Colin L. Masters publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Colin L. Masters sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 1,592 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Colin L. Masters D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Colin L. Masters sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 177 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Australia Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Neuroscience in Australia Leader Award
  • 2023 - Research.com Biology and Biochemistry in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2022 - Research.com Biology and Biochemistry in Australia Leader Award
  • 2015 - Fellow of the Australian Academy of Health and Medical Science

Overview

Colin L. Masters is affiliated with the University of Melbourne in Australia. Their research primarily focuses on medicine, with significant contributions to physiology, psychiatry and mental health, molecular biology, neurology, and cognitive neuroscience.

The scientist's work centers on several key topics: Alzheimer's disease research and treatments, dementia and cognitive impairment research, functional brain connectivity studies, advanced neuroimaging techniques and applications, health, environment, cognitive aging, neuroinflammation and neurodegeneration mechanisms, and prion diseases and protein misfolding.

Recent notable publications include:

  • The Amyloid-β Pathway in Alzheimer's Disease (2021, Molecular Psychiatry)
  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease (2020, Nature Medicine)
  • Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline (2022, Nature Medicine)
  • MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14,468 individuals worldwide (2020, Brain)
  • A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease (2021, Nature Medicine)

Frequent co-authors in their research collaborations include:

  • Ralph N. Martins (105 joint publications)
  • Christopher C. Rowe (104 joint publications)
  • Victor L. Villemagne (96 joint publications)
  • Christopher Fowler (84 joint publications)
  • Paul Maruff (78 joint publications)

The scientist has published extensively in several venues, with the highest number of works found in Alzheimer s & Dementia, followed by bioRxiv (Cold Spring Harbor Laboratory), Journal of Alzheimer s Disease, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, and Nature Communications.

Awards include being named a Fellow of the Australian Academy of Health and Medical Science in 2015.

Best Publications

  • Amyloid plaque core protein in Alzheimer disease and Down syndrome

    Colin L. Masters;Gail Simms;Nicola A. Weinman;Gerd Multhaup

  • Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

    Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan

  • Neurodegenerative diseases and oxidative stress.

    Kevin J. Barnham;Colin L. Masters;Ashley I. Bush;Ashley I. Bush

  • Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

    Catriona A. McLean;Robert A. Cherny;Fiona W. Fraser;Stephanie J. Fuller

  • Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

    Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown

  • Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

    Robert A Cherny;Craig S Atwood;Michel E Xilinas;Danielle N Gray

  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease

    Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato

  • The Amyloid-β Pathway in Alzheimer's Disease.

    Harald Hampel;John Hardy;Kaj Blennow;Kaj Blennow;Christopher Chen

  • Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

    C L Masters;G Multhaup;G Simms;J Pottgiesser

  • Imaging beta-amyloid burden in aging and dementia.

    Christopher C Rowe;Steven Ng;Uwe Ackermann;Sylvia Gong

  • Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

    Craig W Ritchie;Ashley I Bush;Andrew J Mackinnon;Steve Macfarlane

  • The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

    Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio

  • Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

    Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat

  • Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease

    Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis

  • The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)

    Gerd Multhaup;Andrea Schlicksupp;Lars Hesse;Dirk Beher

  • Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

    Tobias Hartmann;Sophie C. Bieger;Babara Brühl;Pentti J. Tienari

  • Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

    Kerryn Elizabeth Pike;Gregory Raymond Savage;Victor L Villemagne;Steven Ng

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    Oliver Preische;Oliver Preische;Stephanie A. Schultz;Anja Apel;Anja Apel;Jens Kuhle

  • Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

    Lars Lannfelt;Kaj Blennow;Henrik Zetterberg;Stellan Batsman

  • Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits

    Cyril C. Curtain;Feda Ali;Irene Volitakis;Robert A. Cherny

  • Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

    Baden Rumble;Robert Retallack;Caroline Hilbich;Gail Simms

  • Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease

    James A. Duce;Andrew Tsatsanis;Michael A. Cater;Simon A. James

Frequent Co-Authors

Christopher C. Rowe
Christopher C. Rowe University of Melbourne
Victor L. Villemagne
Victor L. Villemagne University of Pittsburgh
Ralph N. Martins
Ralph N. Martins Edith Cowan University
David Ames
David Ames University of Melbourne
Konrad Beyreuther
Konrad Beyreuther Heidelberg University
Ashley I. Bush
Ashley I. Bush Florey Institute of Neuroscience and Mental Health
Kathryn A. Ellis
Kathryn A. Ellis University of Melbourne
Roberto Cappai
Roberto Cappai University of Melbourne
Kevin J. Barnham
Kevin J. Barnham Florey Institute of Neuroscience and Mental Health
Cassandra Szoeke
Cassandra Szoeke University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in neuroscience can open doors to diverse fields in mental health, research, and counseling. For those seeking flexible options, online programs are becoming increasingly popular among students and working professionals.

If you are interested in social work and wish to make a fast start in your career, accelerated msw programs online can prepare you for clinical or community-based roles. Those wanting to explore the human mind further may wish to consider accelerated psychology programs online for more targeted or specialized study.

Counseling is also a natural pathway, and it’s important to choose the right accreditation for this field. For high-quality programs, look into cacrep accredited programs online. If affordability is a top priority, you might also explore the cheapest online masters in mental health counseling for programs that combine value with strong academic credentials.

Each of these online degree pathways can complement a foundation in neuroscience and support careers that make a real difference in people’s lives.

Best Scientists Citing Colin L. Masters

Trending Scientists